Alert detail
LCD L37905: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test — CGS Administrators
What changed
Envisia and Veracyte IPF tests covered under Medicare LCD.
Who’s affected: Pulmonology billing teams · Effective: May 28, 2026
Affected codes
Codes81554
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 1 billing code.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.